Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology (2023)
Helen Zhao (Author)
DiMarco, Marina (Author)
Kelsey Ichikawa (Author)
Marion Boulicault (Author)
Meg Perret (Author)
Kai Jillson (Author)
Alexandra Fair (Author)
Kai DeJesus (Author)
Richardson, Sarah S. (Author)
Social Studies of Science
Volume: 53
Issue: 4
Pages: 475-494
The U.S. Food and Drug Administration’s (FDA) 2013 decision to lower recommended Ambien dosing for women has been widely cited as a hallmark example of the importance of sex differences in biomedicine. Using regulatory documents, scientific publications, and media coverage, this article analyzes the making of this highly influential and mobile ‘sex-difference fact’. As we show, the FDA’s decision was a contingent outcome of the drug approval process. Attending to how a contested sex-difference fact came to anchor elite women’s health advocacy, this article excavates the role of regulatory processes, advocacy groups, and the media in producing perceptions of scientific agreement while foreclosing ongoing debate, ultimately enabling the stabilization of a binary, biological sex-difference fact and the distancing of this fact from its conditions of construction.
...MoreSimilar Citations
Book
Carpenter, Daniel;
(2010)
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA
(/isis/citation/CBB001020607/)
Article
Gabriel, Joseph M.;
(2011)
Restricting the Sale of “Deadly Poisons”: Pharmacists, Drug Regulation, and Narratives of Suffering in the Gilded Age
(/isis/citation/CBB001220743/)
Article
Kahn, Jonathan;
(2008)
Exploiting Race in Drug Development: BiDil's Interim Model of Pharmacogenomics
(/isis/citation/CBB000953517/)
Article
Carpenter, Daniel;
Tobbell, Dominique A.;
(2011)
Bioequivalence: The Regulatory Career of a Pharmaceutical Concept
(/isis/citation/CBB001034208/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2013)
Ways of Regulating Drugs in the 19th and 20th Centuries
(/isis/citation/CBB001252493/)
Article
Thembisa Waetjen;
(2019)
The Politics of Narcotic Medicines in Early Twentieth-Century South Africa
(/isis/citation/CBB078457844/)
Book
Carstairs, Catherine;
(2006)
Jailed for Possession: Illegal Drug Use, Regulation, and Power in Canada, 1920--1961
(/isis/citation/CBB000930583/)
Book
Bita Moghaddam;
(2021)
Ketamine
(/isis/citation/CBB929329054/)
Book
Mikkael A. Sekeres;
(2022)
Drugs and the FDA: Safety, Efficacy, and the Public's Trust
(/isis/citation/CBB614307145/)
Book
Nancy D. Campbell;
(2020)
OD: Naloxone and the Politics of Overdose
(/isis/citation/CBB601007525/)
Article
Arthur Daemmrich;
(2019)
Welcoming (Newbie) Scholars to the Field
(/isis/citation/CBB904595256/)
Article
Daemmrich, Arthur;
(2007)
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation.
(/isis/citation/CBB000932013/)
Article
Hicks, Jesse;
(2010)
The Pursuit of Sweet: A History of Saccharin
(/isis/citation/CBB001021092/)
Article
Brushwood, David B.;
(2009)
Recent Trends in Pharmacy Law and Regulation
(/isis/citation/CBB000933447/)
Article
Abraham, John;
Davis, Courtney;
(2010)
Discovery and Management of Adverse Drug Reactions: The Nomifensine Hypersensitivity Syndrome, 1977--1986
(/isis/citation/CBB000932837/)
Book
Tobbell, Dominique A.;
(2012)
Pills, Power, and Policy: The Struggle for Drug Reform in Cold War America and Its Consequences
(/isis/citation/CBB001221127/)
Article
Cooper, Dale;
(2007)
Why Campbell Crossed the Street: Consumers' Research Attempts to Instigate a Purge of the FDA
(/isis/citation/CBB000932012/)
Book
Erlen, Jonathon;
Spillane, Joseph F.;
(2004)
Federal Drug Control: The Evolution of Policy and Practice
(/isis/citation/CBB000641539/)
Book
Sarah S. Richardson;
(2021)
The Maternal Imprint: The Contested Science of Maternal-Fetal Effects
(/isis/citation/CBB755948278/)
Book
Kaushik Sunder Rajan;
(2017)
Pharmocracy: Value, Politics, and Knowledge in Global Biomedicine
(/isis/citation/CBB643725178/)
Be the first to comment!